Borja-Magno Angélica, Guevara-Cruz Martha, Flores-López Adriana, Carrillo-Domínguez Silvia, Granados Julio, Arias Clorinda, Perry Mary, Sears Barry, Bourges Hector, Gómez F Enrique
Departamento de Fisiología de la Nutrición, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Servicio de Nutriología Clínica, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Front Nutr. 2023 May 5;10:1156995. doi: 10.3389/fnut.2023.1156995. eCollection 2023.
Obesity is complicated by low-grade chronic inflammation characterised by increases in inflammatory proteins and cells in peripheral blood. It has been known that omega-3 fatty acids (FA) like eicosapentaenoic (EPA) and docosahexaenoic (DHA) could modulate the inflammatory process and improve metabolic markers.
This study aimed to determine the effect of high-dose omega-3 FA on metabolic and inflammatory markers among patients with obesity and healthy volunteers.
This prospective study included 12 women with obesity (body mass index [BMI] ≥ 35.0 kg/m) and 12 healthy women (BMI < 24.0 kg/m) who were supplemented with a dose of 4.8 g/day (3.2 g EPA plus 1.6 g DHA) for 3 months followed by no treatment for 1 month. Plasma metabolic and inflammatory markers and levels of mRNA transcripts of CD4 T lymphocyte subsets were determined monthly.
None of the participants exhibited changes in weight or body composition after study completion. EPA and DHA supplementation improved metabolic (insulin, Homeostatic Model Assessment of Insulin Resistance [HOMA-IR], triglyceride [TG]/ high-density lipoprotein [HDL] ratio, TG, and arachidonic acid [AA]/EPA ratio) and tumor necrosis factor-alpha (TNF-α). Moreover, the levels of mRNA transcripts of T CD4 lymphocyte subsets (TBX21, IFNG, GATA-3, interleukin [IL]-4, FOXP3, IL-10 IL-6, and TNF-α), were down-regulated during the intervention phase. After 1 month without supplementation, only insulin, HOMA-IR and the mRNA transcripts remained low, whereas all other markers returned to their levels before supplementation.
Supplementation with high-dose omega-3 FAs could modulate metabolism and inflammation in patients with obesity without weight loss or changes in body composition. However, these modulatory effects were ephemeral and with clear differential effects: short-duration on metabolism and long-lasting on inflammation.
肥胖症伴有低度慢性炎症,其特征是外周血中炎症蛋白和细胞增加。已知二十碳五烯酸(EPA)和二十二碳六烯酸(DHA)等ω-3脂肪酸可以调节炎症过程并改善代谢指标。
本研究旨在确定高剂量ω-3脂肪酸对肥胖患者和健康志愿者的代谢及炎症指标的影响。
这项前瞻性研究纳入了12名肥胖女性(体重指数[BMI]≥35.0kg/m²)和12名健康女性(BMI<24.0kg/m²),她们每天补充4.8克(3.2克EPA加1.6克DHA),持续3个月,随后1个月不进行治疗。每月测定血浆代谢和炎症指标以及CD4 T淋巴细胞亚群的mRNA转录水平。
研究结束后,所有参与者的体重或身体成分均未出现变化。补充EPA和DHA改善了代谢指标(胰岛素、胰岛素抵抗稳态模型评估[HOMA-IR]、甘油三酯[TG]/高密度脂蛋白[HDL]比值、TG和花生四烯酸[AA]/EPA比值)以及肿瘤坏死因子-α(TNF-α)。此外,在干预阶段,T CD4淋巴细胞亚群(TBX21、IFNG、GATA-3、白细胞介素[IL]-4、FOXP3、IL-10、IL-6和TNF-α)的mRNA转录水平下调。在不补充的1个月后,只有胰岛素、HOMA-IR和mRNA转录水平仍然较低,而所有其他指标恢复到补充前的水平。
补充高剂量ω-3脂肪酸可以调节肥胖患者的代谢和炎症,而不会导致体重减轻或身体成分改变。然而,这些调节作用是短暂的,且具有明显的差异效应:对代谢的影响持续时间短,对炎症的影响持续时间长。